Aminowill participated in the much-anticipated CPHI Korea exhibition held in Seoul, South Korea from August 27 to 29, 2024. The event provided the company with an ideal platform to showcase its amino acid solutions to industry professionals, researchers and potential partners from around the world.
At the exhibition, Aminowill highlighted its extensive portfolio of amino acid active pharmaceutical ingredients (APIs), infant formula, nutritional amino acid culture media and pharmaceutical intermediate fine chemicals. These products are suitable for various industries such as pharmaceuticals, food and beverages, and biotechnology.
Amino focuses on meeting the evolving needs of the pharmaceutical industry, and its amino acid APIs attracted a lot of attention at the exhibition. These high-quality ingredients are fundamental building blocks for the production of pharmaceuticals, ensuring their efficacy and safety. Ameno’s commitment to GMP standards guarantees that these APIs meet the stringent quality requirements of the pharmaceutical industry.
In addition, Ameno’s infant formula, enriched with essential amino acids, attracted great interest from attendees. As a trusted manufacturer, the company recognizes the importance of providing safe and nutritious products for infants. Ameno aims to support the healthy growth and development of infants around the world by incorporating amino acids into its formulas.
In addition, Ameno’s nutritional amino acid media have been acclaimed for their role in promoting the growth of a variety of microorganisms used in biotechnological applications. These media provide the necessary nutrients for the cultivation of bacteria, yeast, and other cells, enabling the production of valuable biopharmaceuticals and biofuels.
The show also provided Aminowill with the opportunity to showcase its pharmaceutical intermediate fine chemicals. These amino acids play a vital role in the synthesis of complex pharmaceutical compounds, contributing to the growth of the pharmaceutical industry.
By participating in the CPHI Korea show, Aminowill demonstrated its commitment to building partnerships and collaborations within the global amino acid industry. The event provided a platform for the company to exchange knowledge, explore emerging trends, and establish valuable connections with peers in the industry.
As Aminowill continues to expand its presence in international markets, its participation in shows such as CPHI in Korea reinforces its commitment to providing high-quality amino acid solutions. With its advanced fermentation technology, adherence to GMP standards, and diverse product line, Aminowill will remain at the forefront of amino acid manufacturing to meet the ever-changing needs of various industries around the world.
Previous news
